How gut microbes talk to organs: The role of endocrine and nervous routes

Molecular Metabolism

Volumn 5, Issue 9, 2016, Pages 743-752

  Cani, Patrice D ^a,b   Knauf, Claude ^a,b,c,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UMR 1220 TCEM (INRA ENITAB)   (France)

Author keywords

Central nervous system; Enteric nervous system; Enteroendocrine cells; Gut microbiota; Immune system; Metabolites

Indexed keywords

4 AMINOBUTYRIC ACID; BACTERIAL PROTEIN; FFAR2 PROTEIN; FFAR3 PROTEIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; LEPTIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PEPTIDE YY; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID METABOLISM; APPETITE; AUTISM; BIFIDOBACTERIUM INFANTIS; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CLOSTRIDIUM SPOROGENES; DISEASE ASSOCIATION; ENDOCRINE SYSTEM; ENERGY METABOLISM; ESCHERICHIA COLI; FOOD INTAKE; HORMONE SYNTHESIS; HOST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN SENSITIVITY; INTESTINE FLORA; INTESTINE INNERVATION; LIPID DIET; METABOLIC REGULATION; METABOLITE; MUSCLE SPINDLE AFFERENT NERVE; NERVOUS SYSTEM; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 84975678760     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.05.011     Document Type: Review

References (123)

1. [1] Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
2. [2] Dewulf, E.M., Cani, P.D., Claus, S.P., Fuentes, S., Puylaert, P.G., Neyrinck, A.M., et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62 (2013), 1112–1121.
3. [3] Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
4. [4] Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125 (1995), 1401–1412.
5. [5] Bindels, L.B., Delzenne, N.M., Cani, P.D., Walter, J., Towards a more comprehensive concept for prebiotics. Nature Reviews. Gastroenterology & Hepatology 12 (2015), 303–310.
6. [6] Delzenne, N.M., Neyrinck, A.M., Backhed, F., Cani, P.D., Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature reviews. Endocrinology 7 (2011), 639–646.
7. [7] Anhe, F.F., Roy, D., Pilon, G., Dudonne, S., Matamoros, S., Varin, T.V., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64 (2015), 872–883.
8. [8] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
9. [9] David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
10. [10] Al-Lahham, S.H., Peppelenbosch, M.P., Roelofsen, H., Vonk, R.J., Venema, K., Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochimica et Biophysica Acta 1801 (2010), 1175–1183.
11. [11] Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., Macfarlane, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987), 1221–1227.
12. [12] Delzenne, N.M., Williams, C.M., Prebiotics and lipid metabolism. Current Opinion in Lipidology 13 (2002), 61–67.
13. [13] De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (2014), 84–96.
14. [14] Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 278 (2003), 11312–11319.
15. [15] Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. The Journal of Biological Chemistry 278 (2003), 25481–25489.
16. [16] Kimura, I., Inoue, D., Hirano, K., Tsujimoto, G., The SCFA receptor GPR43 and energy metabolism. Frontiers in Endocrinology, 5, 2014, 85.
17. [17] Hong, Y.H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146 (2005), 5092–5099.
18. [18] Dewulf, E.M., Cani, P.D., Neyrinck, A.M., Possemiers, S., Holle, A.V., Muccioli, G.G., et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. The Journal of Nutritional Biochemistry 22 (2011), 712–722.
19. [19] Dewulf, E.M., Ge, Q., Bindels, L.B., Sohet, F.M., Cani, P.D., Brichard, S.M., et al. Evaluation of the relationship between GPR43 and adiposity in human. Nutrition & Metabolism, 10, 2013, 11.
20. [20] Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.L., et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149 (2008), 4519–4526.
21. [21] Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
22. [22] Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
23. [23] Macia, L., Thorburn, A.N., Binge, L.C., Marino, E., Rogers, K.E., Maslowski, K.M., et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunological Reviews 245 (2012), 164–176.
24. [24] Cani, P.D., Dewever, C., Delzenne, N.M., Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. The British Journal of Nutrition 92 (2004), 521–526.
25. [25] Delzenne, N.M., Neyrinck, A.M., Cani, P.D., Gut microbiota and metabolic disorders: how prebiotic can work?. The British Journal of Nutrition 109:Suppl 2 (2013), S81–S85.
26. [26] Birt, D.F., Boylston, T., Hendrich, S., Jane, J.L., Hollis, J., Li, L., et al. Resistant starch: promise for improving human health. Advances in Nutrition 4 (2013), 587–601.
27. [27] Delzenne, N.M., Cani, P.D., Daubioul, C., Neyrinck, A.M., Impact of inulin and oligofructose on gastrointestinal peptides. The British Journal of Nutrition 93:Suppl 1 (2005), S157–S161.
28. [28] Aziz, A.A., Kenney, L.S., Goulet, B., Abdel-Aal, E., Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. Journal of Nutrition 139 (2009), 1881–1889.
29. [29] Charrier, J.A., Martin, R.J., McCutcheon, K.L., Raggio, A.M., Goldsmith, F., Goita, M., et al. High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize. Obesity (Silver Spring), 2013.
30. [30] Keenan, M.J., Zhou, J., McCutcheon, K.L., Raggio, A.M., Bateman, H.G., Todd, E., et al. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 14 (2006), 1523–1534.
31. [31] Shen, L., Keenan, M.J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., et al. Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) 17 (2009), 40–45.
32. [32] Zhou, J., Hegsted, M., McCutcheon, K.L., Keenan, M.J., Xi, X., Raggio, A.M., et al. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 14 (2006), 683–689.
33. [33] Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. American Journal of Physiology – Endocrinology and Metabolism 295 (2008), E1160–E1166.
34. [34] Neyrinck, A.M., Van Hee, V.F., Piront, N., De Backer, F., Toussaint, O., Cani, P.D., et al. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutrition & Diabetes, 2, 2012, e28.
35. [35] Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., et al. Prebiotic effects: metabolic and health benefits. The British Journal of Nutrition 104 (2010), S1–S63.
36. [36] Everard, A., Lazarevic, V., Gaia, N., Johansson, M., Stahlman, M., Backhed, F., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. The ISME Journal 8 (2014), 2116–2130.
37. [37] Nohr, M.K., Pedersen, M.H., Gille, A., Egerod, K.L., Engelstoft, M.S., Husted, A.S., et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 (2013), 3552–3564.
38. [38] Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 16767–16772.
39. [39] Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., Diakogiannaki, E., et al. Short-chain fatty acids stimulate glucagon-like Peptide-1 secretion via the g-protein-coupled receptor FFAR2. Diabetes 61 (2012), 364–371.
40. [40] Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M., Burcelin, R., Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55 (2006), 1484–1490.
41. [41] Cani, P.D., Hoste, S., Guiot, Y., Delzenne, N.M., Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. The British Journal of Nutrition 98 (2007), 32–37.
42. [42] Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (2011), 2775–2786.
43. [43] Wichmann, A., Allahyar, A., Greiner, T.U., Plovier, H., Lunden, G.O., Larsson, T., et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host & Microbe 14 (2013), 582–590.
44. [44] Ropert, A., Cherbut, C., Roze, C., Le Quellec, A., Holst, J.J., Fu-Cheng, X., et al. Colonic fermentation and proximal gastric tone in humans. Gastroenterology 111 (1996), 289–296.
45. [45] Piche, T., des Varannes, S.B., Sacher-Huvelin, S., Holst, J.J., Cuber, J.C., Galmiche, J.P., Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124 (2003), 894–902.
46. [46] Archer, B.J., Johnson, S.K., Devereux, H.M., Baxter, A.L., Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. The British Journal of Nutrition 91 (2004), 591–599.
47. [47] Whelan, K., Efthymiou, L., Judd, P.A., Preedy, V.R., Taylor, M.A., Appetite during consumption of enteral formula as a sole source of nutrition: the effect of supplementing pea-fibre and fructo-oligosaccharides. The British Journal of Nutrition 96 (2006), 350–356.
48. [48] Cani, P.D., Joly, E., Horsmans, Y., Delzenne, N.M., Oligofructose promotes satiety in healthy human: a pilot study. The European Journal of Clinical Nutrition 60 (2006), 567–572.
49. [49] Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. The American Journal of Clinical Nutrition 90 (2009), 1236–1243.
50. [50] Parnell, J.A., Reimer, R.A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. The American Journal of Clinical Nutrition 89 (2009), 1751–1759.
51. [51] Peters, H.P., Boers, H.M., Haddeman, E., Melnikov, S.M., Qvyjt, F., No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. The American Journal of Clinical Nutrition 89 (2009), 58–63.
52. [52] Tarini, J., Wolever, T.M., The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Applied Physiology, Nutrition, and Metabolism 35 (2010), 9–16.
53. [53] Klosterbuer, A.S., Thomas, W., Slavin, J.L., Resistant starch and pullulan reduce postprandial glucose, insulin, and GLP-1, but have no effect on satiety in healthy humans. Journal of Agricultural and Food Chemistry 60 (2012), 11928–11934.
54. [54] Frost, G., Brynes, A., Leeds, A., Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease. Nutrition 15 (1999), 183–188.
55. [55] Bird, A.R., Conlon, M.A., Christophersen, C.T., Topping, D.L., Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Beneficial Microbes 1 (2010), 423–431.
56. [56] Robertson, M.D., Dietary-resistant starch and glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 15 (2012), 362–367.
57. [57] Nilsson, A., Johansson, E., Ekstrom, L., Bjorck, I., Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS One, 8, 2013, e59985.
58. [58] Daud, N.M., Ismail, N.A., Thomas, E.L., Fitzpatrick, J.A., Bell, J.D., Swann, J.R., et al. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity (Silver Spring) 22 (2014), 1430–1438.
59. [59] Spiegelman, B.M., Flier, J.S., Obesity and the regulation of energy balance. Cell 104 (2001), 531–543.
60. [60] Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 334 (1996), 292–295.
61. [61] Anini, Y., Brubaker, P.L., Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 52 (2003), 252–259.
62. [62] Schele, E., Grahnemo, L., Anesten, F., Hallen, A., Backhed, F., Jansson, J.O., The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology 154 (2013), 3643–3651.
63. [63] Unger, T.J., Calderon, G.A., Bradley, L.C., Sena-Esteves, M., Rios, M., Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 27 (2007), 14265–14274.
64. [64] Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 (2007), 2374–2383.
65. [65] Cani, P.D., Possemiers, S., Van de, W.T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
66. [66] Milanski, M., Arruda, A.P., Coope, A., Ignacio-Souza, L.M., Nunez, C.E., Roman, E.A., et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61 (2012), 1455–1462.
67. [67] Bindels, L.B., Porporato, P., Dewulf, E.M., Verrax, J., Neyrinck, A.M., Martin, J.C., et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. British Journal of Cancer 107 (2012), 1337–1344.
68. [68] Zaibi, M.S., Stocker, C.J., O'Dowd, J., Davies, A., Bellahcene, M., Cawthorne, M.A., et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Letter 584 (2010), 2381–2386.
69. [69] Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M.A., Motoike, T., Kedzierski, R.M., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 1045–1050.
70. [70] Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications, 5, 2014, 3611.
71. [71] Rhee, S.H., Pothoulakis, C., Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Reviews. Gastroenterology & Hepatology 6 (2009), 306–314.
72. [72] Barajon, I., Serrao, G., Arnaboldi, F., Opizzi, E., Ripamonti, G., Balsari, A., et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. Journal of Histochemistry & Cytochemistry 57 (2009), 1013–1023.
73. [73] Brun, P., Giron, M.C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145 (2013), 1323–1333.
74. [74] Forsythe, P., Kunze, W.A., Voices from within: gut microbes and the CNS. Cellular and Molecular Life Sciences: CMLS 70 (2013), 55–69.
75. [75] McVey Neufeld, K.A., Mao, Y.K., Bienenstock, J., Foster, J.A., Kunze, W.A., The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 25 (2013), 183–e188.
76. [76] Kabouridis, P.S., Lasrado, R., McCallum, S., Chng, S.H., Snippert, H.J., Clevers, H., et al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85 (2015), 289–295.
77. [77] Rao, M., Gershon, M.D., Bugs, guts, and glia: how microbiota influence enteric gliogenesis and migration. Neuron 85 (2015), 229–230.
78. [78] Erny, D., Hrabe de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience 18 (2015), 965–977.
79. [79] Breton, J., Tennoune, N., Lucas, N., Francois, M., Legrand, R., Jacquemot, J., et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metabolism 23 (2016), 324–334.
80. [80] Tennoune, N., Chan, P., Breton, J., Legrand, R., Chabane, Y.N., Akkermann, K., et al. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide alpha-MSH, at the origin of eating disorders. Translational Psychiatry, 4, 2014, e458.
81. [81] Ji, X.B., Hollocher, T.C., Reduction of nitrite to nitric oxide by enteric bacteria. Biochemical and Biophysical Research Communications 157 (1988), 106–108.
82. [82] Salzman, A.L., Nitric oxide in the gut. New Horizons 3 (1995), 352–364.
83. [83] Garthwaite, J., Charles, S.L., Chess-Williams, R., Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (1988), 385–388.
84. [84] Gusarov, I., Starodubtseva, M., Wang, Z.Q., McQuade, L., Lippard, S.J., Stuehr, D.J., et al. Bacterial nitric-oxide synthases operate without a dedicated redox partner. The Journal of Biological Chemistry 283 (2008), 13140–13147.
85. [85] Gusarov, I., Shatalin, K., Starodubtseva, M., Nudler, E., Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325 (2009), 1380–1384.
86. [86] Williams, B.B., Van Benschoten, A.H., Cimermancic, P., Donia, M.S., Zimmermann, M., Taketani, M., et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host & Microbe 16 (2014), 495–503.
87. [87] Takaki, M., Mawe, G.M., Barasch, J.M., Gershon, M.D., Gershon, M.D., Physiological responses of guinea-pig myenteric neurons secondary to the release of endogenous serotonin by tryptamine. Neuroscience 16 (1985), 223–240.
88. [88] Barrett, E., Ross, R.P., O'Toole, P.W., Fitzgerald, G.F., Stanton, C., Gamma-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology 113 (2012), 411–417.
89. [89] Hyland, N.P., Cryan, J.F., A gut feeling about GABA: focus on GABA(B) receptors. Frontiers in Pharmacology, 1, 2010, 124.
90. [90] Clarke, G., Stilling, R.M., Kennedy, P.J., Stanton, C., Cryan, J.F., Dinan, T.G., Minireview: gut microbiota: the neglected endocrine organ. Molecular Endocrinology 28 (2014), 1221–1238.
91. [91] Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., et al. The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine, 6, 2014, 263ra158.
92. [92] Li, Q., Zhou, J.M., The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 324 (2016), 131–139.
93. [93] Adams, J.B., Johansen, L.J., Powell, L.D., Quig, D., Rubin, R.A., Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterology, 11, 2011, 22.
94. [94] Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Digestive Diseases and Sciences 57 (2012), 2096–2102.
95. [95] El-Ansary, A.K., Ben Bacha, A., Kotb, M., Etiology of autistic features: the persisting neurotoxic effects of propionic acid. Journal of Neuroinflammation, 9, 2012, 74.
96. [96] Macfabe, D.F., Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microbial Ecology in Health and Disease, 23, 2012.
97. [97] Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology 558 (2004), 263–275.
98. [98] Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141, 2011 599–609, 609 e591–593.
99. [99] Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
100. [100] O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research 277 (2015), 32–48.
101. [101] Perez Martinez, G., Bauerl, C., Collado, M.C., Understanding gut microbiota in elderly's health will enable intervention through probiotics. Beneficial Microbes 5 (2014), 235–246.
102. [102] Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Movement Disorders 30 (2015), 350–358.
103. [103] Wood, H., Parkinson disease. Gut reactions–can changes in the intestinal microbiome provide new insights into Parkinson disease?. Nature Review Neurology, 11, 2015, 66.
104. [104] Ghaisas, S., Maher, J., Kanthasamy, A., Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacology & Therapeutics 158 (2016), 52–62.
105. [105] Cani, P.D., Everard, A., Talking microbes: when gut bacteria interact with diet and host organs. Molecular Nutrition & Food Research 60 (2016), 58–66.
106. [106] Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
107. [107] Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Digestive Diseases and Sciences, 2011.
108. [108] Bogunovic, M., Dave, S.H., Tilstra, J.S., Chang, D.T., Harpaz, N., Xiong, H., et al. Enteroendocrine cells express functional Toll-like receptors. American Journal of Physiology. Gastrointestinal and Liver Physiology 292 (2007), G1770–G1783.
109. [109] de La Serre, C.B., de Lartigue, G., Raybould, H.E., Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiology & Behavior 139 (2015), 188–194.
110. [110] Adolph, T.E., Tomczak, M.F., Niederreiter, L., Ko, H.J., Bock, J., Martinez-Naves, E., et al. Paneth cells as a site of origin for intestinal inflammation. Nature 503 (2013), 272–276.
111. [111] Rosenstiel, P., Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine. Current Opinion in Gastroenterology 29 (2013), 125–132.
112. [112] Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
113. [113] Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 7, 2012, e47713.
114. [114] Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
115. [115] Hosoi, T., Yokoyama, S., Matsuo, S., Akira, S., Ozawa, K., Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS One, 5, 2010, e12537.
116. [116] Kleinridders, A., Schenten, D., Konner, A.C., Belgardt, B.F., Mauer, J., Okamura, T., et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metabolism 10 (2009), 249–259.
117. [117] Yokoyama, S., Hosoi, T., Ozawa, K., Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice. Gene 497 (2012), 340–343.
118. [118] Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nature Communications, 5, 2014, 5648.
119. [119] Duparc, T., Plovier, H., Marrachelli, V.G., Van Hul, M., Essaghir, A., Stahlman, M., et al. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut, 2016, 10.1136/gutjnl-2015-310904. pii: gutjnl-2015-310904.[in press].
120. [120] Galbo, T., Perry, R.J., Jurczak, M.J., Camporez, J.P., Alves, T.C., Kahn, M., et al. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo. Proceedings of the National Academy of Sciences of the United States of America 110 (2013), 12780–12785.
121. [121] Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 116 (2006), 3015–3025.
122. [122] Erridge, C., Samani, N.J., Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arteriosclerosis, Thrombosis, and Vascular Biology 29 (2009), 1944–1949.
123. [123] Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine 18 (2012), 1279–1285.